The primary objectives of this research project is to analyze the constituents derived from synthetic coolant in heated aerosols and to perform cytotoxicity and genotoxicity screening on pulmonary…
Ended Definitive Contract Awarded Last action
- Contract number
- 75F40123C00215
- Awardee
-
University Of Rochester UEI F27KDXZMF9Y8
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $846,191
Award facts
- Contract value 100% obligated
- $846,191.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 2 offers Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Rochester, NY 14611, USA
- Legislative mandates
-
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $0 | |
| Original award | $846,191 |
About this award
The University of Rochester received a $846,191 firm fixed-price definitive contract from the Food and Drug Administration (FDA) via bilateral modification to extend performance through June 30, 2026. The research initiative analyzes chemical constituents derived from synthetic coolant in heated aerosols and conducts cytotoxicity and genotoxicity screening on pulmonary cells exposed to synthetic coolant aerosols. Work is performed in Rochester, New York, with no small business set-aside designation applied to this competitive award originally initiated on September 27, 2023. The FDA's interest in this research reflects the agency's mission to protect public health by evaluating occupational and environmental health risks associated with industrial materials.
The University of Rochester subcontracted portions of this work to The Research Foundation for the State University of New York (RF SUNY), doing business as Sponsored Projects Services, under a sub-award issued February 18, 2025, focusing on synthetic coolant aerosol chemical constituent analysis and in vitro respiratory toxicity assessment. As a private research university with extensive federal contracting experience across biomedical research, advanced technology development, and clinical services, the University of Rochester brings established capabilities in pulmonary health research and toxicology screening. RF SUNY, which serves as fiscal agent and sponsored programs administrator for the State University of New York system, provides research administration and execution services across diverse scientific domains, enhancing the prime contractor's ability to deliver comprehensive analytical and testing services required under this initiative.
Description
The primary objectives of this research project is to analyze the constituents derived from synthetic coolant in heated aerosols and to perform cytotoxicity and genotoxicity screening on pulmonary cells treated with synthetic coolant aerosols
Subawards
| Subcontractor | Amount | Awarded |
|---|---|---|
| The Research Foundation For The State University Of New York | $40,551 |
Quick answers
Who was awarded contract 75F40123C00215?
75F40123C00215 was awarded to University Of Rochester by Food and Drug Administration (Department of Health and Human Services) on September 27, 2023.
How much is contract 75F40123C00215 worth?
The government has obligated $846,191 on 75F40123C00215.
Was contract 75F40123C00215 competed?
The extent of competition for 75F40123C00215 was competed under sap. The government received 2 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award